Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Fatigue in Multiple Sclerosis
NCT01718678Phase 2Completed
- Start
- May 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in multiple sclerosis (MS). Started May 2012; status: completed.
02
Drugs
melatonin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01718678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718678.